https://www.selleckchem.com/products/mln-4924.html
38-4.20, P≤0.004). Excluding patients who died within 90 days after LT, the risk of death after AIH-LT was superior compared to ALC-LT (HR=0.84, P=0.004), worse compared to PBC-LT (HR=1.38, P less then 0.001) and similar compared to PSC-LT (P=0.93). AIH patients with living donor LT (LDLT) showed reduced survival compared to patients receiving donation after brain death (HR=1.96, P less then 0.001). CONCLUSION In AIH-LT patients, overall survival is inferior to PBC-LT and PSC-LT. The high risk of death after AIH-LT is caused mainly by